Loading...
Loading...
Application UK00913613393 · Dead
| Application Number | UK00913613393 |
| Status | Dead |
| Owner | CTL & Ortholabor GmbH |
| Filed | 2014-12-30 |
| Registered | 2015-06-19 |
| Renewal Due | 2024-12-30 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
NeuroSpot has a current status of Dead.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Services of a medical laboratory, In particular testing of saliva, urine, stools or blood for hormones, in particular stress hormones, or neurotransmitters.
Medical services, In particular diagnosis with regard to deviations in hormone or neurotransmitter level from the normal value; Therapy suggestions for doctors or patients, in particular for stress management.
'NeuroSpot' is a dead trademark on the UK IPO register, owned by CTL & Ortholabor GmbH. The application (UK00913613393) was filed on 30 December 2014 and registered on 19 June 2015. The registration is set to expire on 30 December 2024.
This mark is recorded under multiple classes: Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services).
The trademark is represented by WEGNERPARTNER.
UK trademark UK00913613393 for the mark 'NeuroSpot' in Class 42, 44 is recorded on the UK IPO register as owned by CTL & Ortholabor GmbH. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
No — the UK IPO records the status of UK trademark UK00913613393 for the mark 'NeuroSpot' as dead.
UK trademark UK00913613393 for the mark 'NeuroSpot' is recorded in Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 42: Services of a medical laboratory, In particular testing of saliva, urine, stools or blood for hormones, in particular stress hormones, or neurotransmitters. | Class 44: Medical services, In particular diagnosis with regard to deviations in hormone or neurotransmitter level from the normal value; Therapy su…
UK trademark UK00913613393 for the mark 'NeuroSpot' was filed at the UK IPO on 30 December 2014 and registered on 19 June 2015.
UK trademark UK00913613393 for the mark 'NeuroSpot' is currently recorded as valid until 30 December 2024, at which point it will need to be renewed with the UK IPO to remain in force.
WEGNERPARTNER is listed as the attorney / representative of record for UK trademark UK00913613393 for the mark 'NeuroSpot' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.